#5 63/M Generalised
lymphadenopathy Multicentric Mixed Rituximab
PR, received
CHOP at
progression
SD at 28 months
#6 25/M Posterior
mediastinal mass Unicentric Hyaline
vascular Debulking, RT Metabolic CR CR at 26 months
#7 60/M Colonic and
mesenteric mas Unicentric Not known Right
hemicolectomy CR CR at 34 months
#8 45/M Generalised
lymphadenopathy Multicentric Plasma cell CHOP 1 cycle Expired at 3
months
Conclusion
CD is a rare disease. Unicentric disease was more common and had better outcome. Surgery is the
mainstay of management in unicentric disease. Multicentric disease requires combination
chemotherapy.
